RUNX2 and CD4+/CD56+ hematodermic neoplasm: Previous studies reported that t(6;8)(p21;q24) involved adjacent regions to MYC and RUNX2 in the cells of BPDCN patients;7,8,27 however, the biological function of t(6;8) currently remains unclear.